-
Mashup Score: 6Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Ruben Raychaudhuri , Ali Khaki , Mary Redman , Kelsey Baker , Aaron Lin , Brianna Woo , Andrii Hannochka , Nathan Conrad , Funda Vakar-Lopez , Todd Yezefski , Michael Schweizer , Robert Montgomery , Evan Yu , Atreya Dash , Sarah Psutka , Daniel Lin , George Schade , John Gore , Jonathan Wright , Petros Grivas University of Washington & Fred Hutchinson Cancer Center, Stanford University, Fred Hutchinson Cancer Center, Department of Pathology, University of Washington, Department of Urology, University of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 61Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Ding-Wei Ye , Hiroji Uemura , Amitabha Bhaumik , Michael Eisbacher , Anildeep Singh , Sharon McCarthy , Suneel Dinkar Mundle , Kim Chi , Neeraj Agarwal Department of Medical Oncology, Peter MacCallum Cancer Centre, Fudan University Shanghai Cancer Center, Yokohama City University Medical Center, Johnson & Johnson Research and Development, Johnson & Johnson – Australia and New Zealand, Johnson & Johnson, University of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#165 @ASCO #GU25 by @AzadOncology👉https://t.co/CssaQq8peS👉In ph3 TITAN trial in pts w/ mHSPC #prostatecancer👉rPFS & OS improved w/ ADT+APA regardless of prior CV/metabolic baseline risk or concomitant meds👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/fuHZPGW9Nt
-
-
Mashup Score: 42Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Laurence Albiges Gustave Roussy, Paris-Saclay University Laurence Albiges , Cristina Suárez , Thomas Powles , Robert Motzer , Walter Stadler , Wilson Miller Jr., Carlos Rojas , Avivit Peer , Jeffrey Goh , Se Hoon Park , Tom Waddell , Philippe Barthelemy , Pablo Gajate , Andrew Weickhardt , Guy Faust , Rodolfo Perini , Lockman Bousserouel , Ding Wang , Hans Hammers , Katy Beckermann Gustave Roussy, Paris-Saclay University, Vall d’Hebron Institute of Oncology, Hospital Univer sitari Vall d’Hebron, Vall
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#440 @ASCO #GU25 by @AlbigesL👉https://t.co/EdYbRxWxgQ👉Results of ph1 KEYMAKER-U03 #kidneycancer👉Lenvatinib + belzutifan showed durable antitumor activity w/ ORR 47% in mRCC s/p VEGF-TKI+IO👇@katy_beckermann @OncoAlert @urotoday @KidneyCancer @Uromigos https://t.co/rjGxmzPbn2
-
-
Mashup Score: 39Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Tarek Nahle Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University Tarek Nahle , Omar Elsayed , Viraj Shah , Harikrishnan Hyma Kunhiraman , Sami Abi Farraj , Priyanshu Nain , Nickolas Stabellini , Sadeer Al-Kindi , Umang Swami , Jordan Ciuro , Jigarkumar Parikh , Ashanda Esdaille , Zachary Klaassen , Martha Terris , Jennifer Cullen , Neal Weintraub , Neeraj Agarwal , Avirup Guha Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#315 @ASCO #GU25 by @TarekNahle @avirupguha 👉https://t.co/OvC9wLrxab 👉In SEER-Medicare database in pts w/ #prostatecancer 👉Low socioeconomic position associated w/⬆️risk of CV mortality, PCa specific-mortality & all-cause mortality👇@OncoAlert @urotoday @PCF_Science https://t.co/zXktzjVmjO
-
-
Mashup Score: 45Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Laurence Albiges Institut Gustave Roussy, Université Paris Saclay Laurence Albiges , Robert Motzer , Sergio Trevino , Ravindran Kanesvaran , Piotr Centkowski , Melissa Reimers , Juan Pablo Sade , Damien Pouessel , Elisa Biscaldi , Emilio Esteban , Jose Angel Arranz Arija , Scott Tykodi , Haijun Ma , Lei Zhou , Maximiliano Van Kooten Losio , Andrew Simmons , Fatima Rangwala , David Braun , Toni Choueiri , Thomas Powles Institut Gustave Roussy, Universit é Paris Saclay, Memorial Sloan Kettering Cancer
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#438 @ASCO #GU25 by @AlbigesL👉https://t.co/4DArbO5VJr👉Final results of COSMIC-313 trial #kidneycancer👉1L Cabo+Ipi+Nivo vs Ipi+Nivo continues to show PFS & ORR benefit (no OS benefit)👇@tompowles1 @OncoAlert @urotoday @Uromigos @KidneyCancer @kidneycan https://t.co/4eM5zxFYGD
-
-
Mashup Score: 59Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Wenxin Xu Dana-Farber Cancer Institute, Harvard Medical School Wenxin Xu , Sai Vikram Vemula , Robert Motzer , Aparna Chhibber , Deepthi Chowbene , Nahuel Perrot , Xiaowen Liu , Joseph Bonventre , Toni Choueiri , David McDermott , Saurabh Gupta , Rupal Bhatt Dana-Farber Cancer Institute, Harvard Medical School, Bristol Myers Squibb, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College, Beth Israel Deaconess Medical Center, Brigham and Women’s Hospi tal, Dana-Farber
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#437 @ASCO #GU25 by @VincentWenxinXu👉 https://t.co/uiBniVraFJ👉post-hoc analysis of CheckMate214 #kidneycancer👉⬆️KIM-1 associated w/⬇️OS & KIM-1 reduction correlates w/⬆️ Ipi+Nivo efficacy👇 @OncoAlert @urotoday @Uromigos @KidneyCancer @kidneycan https://t.co/KBF8NtKnKr
-
-
Mashup Score: 36Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Robert Motzer , Bernard Escudier , Mauricio Burotto , Thomas Powles , Andrea Apolo , Maria Bourlon , Amishi Shah , Camillo Porta , Cristina Suárez , Carlos Barrios , Martin Richarde t , Howard Gurney , Elizabeth Kessler , Yoshihiko Tomita , Jens Bedke , Fatima Rangwala , Margarita Askelson , Julie Panzica , Viktor Fedorov , Toni Choueiri Memorial Sloan Kettering Cancer Center, Gustave Roussy, Bradford Hill Clinical Research Center, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#439 @ASCO #GU25 by #RobertMotzer👉https://t.co/S6cuNPGX8X👉Final results of CheckMate 9ER #kidneycancer👉Median OS 46.5 vs 35.5 mo w/ 1L Cabo+Nivo vs sunitinib👇@DrChoueiri @OncoAlert @urotoday @KidneyCancer @Uromigos @kidneycan https://t.co/fpIzyG1ydu
-
-
Mashup Score: 45Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Hedyeh Ebrahimi , Luis Meza , Nazli Dizman , Regina Barragan-Carrillo , Xiaochen Li , Marian Llamas-Q uitiquit , Joann Hsu , Zeynep Zengin , Daniela Castro , Benjamin Mercier , Miguel Zugman , Salvador Jaime-Casas , Alex Chehrazi-Raffle , Jeffrey Trent , Peter Lee , Motomichi Takahashi , Tanya Dorff , Gregory Caporaso , Keehoon Lee , Sumanta Pal City of Hope Comprehensive Cancer Center, Yale University School of Medicine, The University of Texas MD Anderson Cancer Center, Translational Genomics Research
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#543 @ASCO #GU25👉congrats @EbrahimiHedyeh for Merit Award👉https://t.co/ybSv4eGkcE👉Combining CBM588 w/ Cabo+Nivo👉associated w/⬆️PFS & ORR in mRCC #kidneycancer👇 @montypal @OncoAlert @urotoday @KidneyCancer @kidneycan https://t.co/J3r3R3TMKm
-
-
Mashup Score: 36Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Robert Motzer , Bernard Escudier , Mauricio Burotto , Thomas Powles , Andrea Apolo , Maria Bourlon , Amishi Shah , Camillo Porta , Cristina Suárez , Carlos Barrios , Martin Richarde t , Howard Gurney , Elizabeth Kessler , Yoshihiko Tomita , Jens Bedke , Fatima Rangwala , Margarita Askelson , Julie Panzica , Viktor Fedorov , Toni Choueiri Memorial Sloan Kettering Cancer Center, Gustave Roussy, Bradford Hill Clinical Research Center, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#439 @ASCO #GU25 by #RobertMotzer👉https://t.co/S6cuNPGX8X👉Final results of CheckMate 9ER #kidneycancer👉Median OS 46.5 vs 35.5 mo w/ 1L Cabo+Nivo vs sunitinib👇@DrChoueiri @OncoAlert @urotoday @KidneyCancer @Uromigos @kidneycan https://t.co/fpIzyG1ydu
-
-
Mashup Score: 76Program Guide – ASCO Meeting Program Guide - 2 month(s) ago
Soumyajit Roy , Yilun Sun , James Eastham , Martin Gleave , Himisha Beltran , Amar Kishan , Angela Jia , Nicholas Zaorsky , Jorge Garcia , Eric Small , Paul Nguyen , Gerhardt Attard , Rana McKay , Alton Sartor , Seth Rosenthal , Susan Halabi , Felix Feng , Michael Morris , Howard Sandler , Daniel Spratt Rush University Medical Center, Case Western Reserve University, Memorial Sloan Kettering Cancer Center, University of British Columbia, Dana-Farber Cancer Institute, Department of Radiation Oncology,
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#309 @ASCO #GU25👉Congrats @Soum_Roy_RadOnc for oral presentation👉https://t.co/ekd36JOaJT👉Pts w/high-risk PCa had ⬇️distant mets with RT compared to radical prostatectomy (emulated randomized comparison) #prostatecancer👇@DrSpratticus @OncoAlert @urotoday @PCF_Science https://t.co/3FSMZNoLUM
-
Ab#769 @ASCO #GU25 👉Congrats @RubenRaychaud @PGrivasMDPhD👉https://t.co/SCnL1Y04hU👉Ph2 trial of neoadj pembro + aMVAC in pts w/ non-urothelial MIBC #bladdercancer👉pCR 53%, median EFS 38 mos & median OS NR👉Promising data👇 @OncoAlert @urotoday @BladdercancerUS https://t.co/KjNMGSYb1Z